Fmoc-Ile-Gly-OH

Fmoc-Ile-Gly-OH is an Fmoc-protected dipeptide acid composed of isoleucine and glycine linked through an amide bond, with the N-terminus masked by the fluorenylmethoxycarbonyl (Fmoc) protecting group and the C-terminus present as a free carboxylic acid. The molecule bears the stereogenic center of the isoleucine residue, enabling stereochemically defined peptide chain extension, while the glycine segment provides conformational flexibility due to its unsubstituted side chain. The Fmoc carbamate is designed for base-labile removal under standard peptide synthesis conditions, and the terminal carboxyl group enables coupling to downstream amino acid building blocks. The combination of a protected N-terminus, an accessible C-terminus, and a defined Ile-Gly sequence makes Fmoc-Ile-Gly-OH a practical peptide fragment for both research-grade synthesis and controlled process routes to defined peptide structures.

1. Peptide Synthesis

Fmoc-Ile-Gly-OH is applied in solid-phase and solution-phase peptide synthesis workflows where a sequence-defined dipeptide building block is needed for stepwise chain assembly. The Fmoc-protected N-terminus supports iterative peptide coupling by enabling controlled deprotection and reactivation cycles, while the free C-terminal carboxylic acid participates in amide bond formation to extend the peptide toward either C-terminal or internal segments. The Ile stereocenter provides stereochemical fidelity for downstream structure-function studies, and the glycine residue can accommodate turn formation or reduce steric bias during scaffold construction. The resulting peptide products can be used to generate defined reference standards, peptide analog libraries, and sequence-precise intermediates for further derivatization.

2. Protected Amino Acid Chemistry

Fmoc-Ile-Gly-OH is suitable for protected amino acid derivative strategies in which Fmoc-based orthogonal handling is required to manage multiple reactive sites during synthesis. The Fmoc carbamate masks the peptide N-terminus to suppress side reactions such as uncontrolled oligomerization, while the C-terminal carboxylic acid remains available for selective coupling chemistry. The Ile-Gly framework functions as a chiral peptide fragment, enabling stereochemically controlled incorporation of isoleucine into larger constructs without requiring separate stereochemical resolution at the fragment stage. The dipeptide acid format aligns with downstream deprotection and coupling steps used to produce longer peptide chains, peptidomimetics, and chemically modified peptide intermediates.

3. Structure-Activity Relationship Studies

Fmoc-Ile-Gly-OH supports structure-activity relationship studies where defined peptide segments are required to probe how local stereochemistry and backbone composition influence molecular recognition. The isoleucine side chain introduces hydrophobic bulk and conformational preferences, while the glycine residue contributes backbone flexibility that can modulate hydrogen-bonding patterns and conformational ensembles. The Fmoc-protected N-terminus enables reproducible assembly of peptide variants by maintaining consistent protection logic across analog series, which is important for comparing structure-dependent outcomes. The dipeptide acid can be incorporated into peptide scaffolds used for SAR mapping, fragment optimization, and mechanistic studies of peptide-mediated interactions in biochemical research settings.

4. Bioconjugation Chemistry

Fmoc-Ile-Gly-OH is utilized in bioconjugation and biomolecule modification workflows where peptide fragments serve as linkers, tags, or recognition elements. The terminal carboxylic acid can be converted into activated derivatives for amide coupling to carrier proteins, polymer backbones, or surface-functionalized materials, while the Fmoc group provides a controlled handle during peptide assembly prior to conjugation. The Ile-Gly sequence can function as a spacer that balances hydrophobic character and conformational mobility, which may influence conjugate solubility and presentation of adjacent functional groups. The resulting conjugates can be applied to generate labeled biomolecular probes, affinity reagents, or peptide-based materials for analytical and biochemical investigation.

5. Pharmaceutical Manufacturing

Fmoc-Ile-Gly-OH is relevant to pharmaceutical manufacturing and process chemistry for the preparation of defined peptide intermediates used in active ingredient synthesis and peptide-based manufacturing campaigns. The Fmoc-protected N-terminus and C-terminal acid form a standardized, scalable fragment that can be integrated into controlled coupling sequences to build longer peptide chains with consistent protection-deprotection behavior. The stereodefined isoleucine residue reduces ambiguity in intermediate identity and supports reproducible downstream purification strategies based on chemical structure rather than stereochemical correction. The dipeptide acid format also aligns with fine chemical production practices where peptide building blocks are handled as discrete, characterization-friendly intermediates for subsequent conversion into final peptide targets or advanced intermediates.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. TMEM16F and dynamins control expansive plasma membrane reservoirs